Lorcaserin hydrochloride
(ITIHHRMYZPNGRC-QRPNPIFTSA-N)
Structure
- SMILES
- Clc1ccc2c(c1)[C@@H](C)CNCC2.Cl
- Molecular Formula:
- C11H15Cl2N
- Molecular Weight:
- 232.150
- Log P:
- 3.7200
- Hydrogen Bond Acceptor:
- 1
- Hydrogen Bond Donor:
- 2
- TPSA:
- 12.03
- CAS Number(s):
- 846589-98-8
Synonym(s)
1.
Lorcaserin hydrochloride
2.
(5R)-7-Chloro-5-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-3-ium;chloride
3.
(5R)-7-Chloro-5-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine;hydron;chloride
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 17 | US FAERS | |
| 2 | Fatigue | FAERS: 11 | US FAERS | |
| 3 | Dizziness | FAERS: 6 | US FAERS | |
| 4 | Headache | FAERS: 6 | US FAERS | |
| 5 | Constipation | FAERS: 4 | US FAERS | |
| 6 | Nausea | FAERS: 4 | US FAERS | |
| 7 | Food craving | FAERS: 3 | US FAERS | |
| 8 | Hunger | FAERS: 3 | US FAERS | |
| 9 | Bradyphrenia | FAERS: 2 | US FAERS | |
| 10 | Depressed mood | FAERS: 2 | US FAERS | |
| 11 | Feeling abnormal | FAERS: 2 | US FAERS | |
| 12 | Lethargy | FAERS: 2 | US FAERS | |
| 13 | Pain | FAERS: 2 | US FAERS | |
| 14 | Abdominal discomfort | FAERS: 1 | US FAERS | |
| 15 | Agitation | FAERS: 1 | US FAERS | |
| 16 | Amnesia | FAERS: 1 | US FAERS | |
| 17 | Anger | FAERS: 1 | US FAERS | |
| 18 | Anxiety | FAERS: 1 | US FAERS | |
| 19 | Asthenia | FAERS: 1 | US FAERS | |
| 20 | Bradycardia | FAERS: 1 | US FAERS | |
| 21 | Chills | FAERS: 1 | US FAERS | |
| 22 | Crying | FAERS: 1 | US FAERS | |
| 23 | Discomfort | FAERS: 1 | US FAERS | |
| 24 | Drug dose omission | FAERS: 1 | US FAERS | |
| 25 | Emotional disorder | FAERS: 1 | US FAERS | |
| 26 | Erectile dysfunction | FAERS: 1 | US FAERS | |
| 27 | Euphoric mood | FAERS: 1 | US FAERS | |
| 28 | Hypotension | FAERS: 1 | US FAERS | |
| 29 | Intentional product misuse | FAERS: 1 | US FAERS | |
| 30 | Memory impairment | FAERS: 1 | US FAERS | |
| 31 | Myalgia | FAERS: 1 | US FAERS | |
| 32 | Palpitations | FAERS: 1 | US FAERS | |
| 33 | Peripheral swelling | FAERS: 1 | US FAERS | |
| 34 | Restlessness | FAERS: 1 | US FAERS | |
| 35 | Somnolence | FAERS: 1 | US FAERS | |
| 36 | Tachyphrenia | FAERS: 1 | US FAERS | |
| 37 | Therapeutic product effect decreased | FAERS: 1 | US FAERS | |
| 38 | Tinnitus | FAERS: 1 | US FAERS | |
| 39 | Urinary tract infection | FAERS: 1 | US FAERS | |
| 40 | Urticaria | FAERS: 1 | US FAERS | |
| 41 | Vomiting | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.